Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioLegacy Research Completes USDA Inspection with Zero Findings | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioLegacy Research Completes USDA Inspection with Zero Findings

Reaffirms its ongoing commitment to high standards of quality, compliance, and animal welfare.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

BioLegacy Research, a contract research organization (CRO) specializing in preclinical services in regulated species, successfully completed its recent USDA inspection, which concluded with zero findings.

The inspection, conducted on September 2, 2025, reaffirms BioLegacy Research’s ongoing commitment to high standards of quality, compliance, and animal welfare. The USDA’s thorough review identified no concerns, underscoring the organization’s dedication to operational excellence and regulatory integrity.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics